Current status of pig heart xenotransplantation
- PMID: 26318967
- PMCID: PMC4684783
- DOI: 10.1016/j.ijsu.2015.08.038
Current status of pig heart xenotransplantation
Abstract
Significant progress in understanding and overcoming cardiac xenograft rejection using a clinically relevant large animal pig-to-baboon model has accelerated in recent years. This advancement is based on improved immune suppression, which attained more effective regulation of B lymphocytes and possibly newer donor genetics. These improvements have enhanced heterotopic cardiac xenograft survival from a few weeks to over 2 years, achieved intrathoracic heterotopic cardiac xenograft survival of 50 days and orthotopic survival of 57 days. This encouraging progress has rekindled interest in xenotransplantation research and refocused efforts on preclinical orthotopic cardiac xenotransplantation.
Keywords: Anti CD154 antibody; Anti CD20 antibody; Anti CD40 antibody; Cardiac xenotransplantation; Heterotopic; Intrathoracic heterotopic; Orthotopic.
Copyright © 2015 IJS Publishing Group Limited. All rights reserved.
Conflict of interest statement
Figures



References
-
- Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141–156. - PubMed
-
- Patel CB, Cowger JA, Zuckermann A. A contemporary review of mechanical circulatory support. J Heart Lung Transplant. 2014;33:667–674. - PubMed
-
- Buhler L, Friedman T, Iacomini J, Cooper DK. Xenotransplantation–state of the art–update 1999. Front Biosci. 1999;4:D416–432. - PubMed
-
- Ekser B, Rigotti P, Gridelli B, Cooper DK. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol. 2009;21:87–92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials